- Home
- BEAM vs RXST Comparison
BEAM vs RXST Comparison
Compare BEAM & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAM
- RXST
- Stock Information
- Founded
- BEAM 2017
- RXST 1997
- Country
- BEAM United States
- RXST United States
- Employees
- BEAM N/A
- RXST N/A
- Industry
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BEAM Health Care
- RXST Health Care
- Exchange
- BEAM Nasdaq
- RXST Nasdaq
- Market Cap
- BEAM 1.9B
- RXST 2.0B
- IPO Year
- BEAM 2020
- RXST 2021
- Fundamental
- Price
- BEAM $23.58
- RXST $45.05
- Analyst Decision
- BEAM Buy
- RXST Strong Buy
- Analyst Count
- BEAM 11
- RXST 8
- Target Price
- BEAM $45.90
- RXST $61.63
- AVG Volume (30 Days)
- BEAM 1.3M
- RXST 673.6K
- Earning Date
- BEAM 11-05-2024
- RXST 11-07-2024
- Dividend Yield
- BEAM N/A
- RXST N/A
- EPS Growth
- BEAM N/A
- RXST N/A
- EPS
- BEAM N/A
- RXST N/A
- Revenue
- BEAM $349,643,000.00
- RXST $128,293,000.00
- Revenue This Year
- BEAM N/A
- RXST $60.19
- Revenue Next Year
- BEAM $6.04
- RXST $34.96
- P/E Ratio
- BEAM N/A
- RXST N/A
- Revenue Growth
- BEAM 328.73
- RXST 67.52
- 52 Week Low
- BEAM $20.84
- RXST $28.54
- 52 Week High
- BEAM $49.50
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- BEAM 45.28
- RXST 37.96
- Support Level
- BEAM $23.67
- RXST $43.98
- Resistance Level
- BEAM $25.87
- RXST $46.81
- Average True Range (ATR)
- BEAM 2.23
- RXST 2.39
- MACD
- BEAM -0.24
- RXST -0.40
- Stochastic Oscillator
- BEAM 19.58
- RXST 19.20
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.